CC vs PODD · P/E 72, rev $1.36B vs P/E 34, rev $2.07B
Chemours Co (CC) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CC currently screens at market cap $1.94B and trailing P/E 71.8. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CC and PODD stock pages for the full models.
Not investment advice.